Results 281 to 290 of about 117,687 (361)

Visibility Evaluation of Fundic Gland Polyp Associated With Proton Pump Inhibitor in Texture and Color Enhancement Imaging. [PDF]

DEN Open
Uchida R, Ueyama H, Takeda T, Nakamura S, Uemura Y, Iwano T, Yamamoto M, Utsunomiya H, Abe D, Oki S, Suzuki N, Ikeda A, Akazawa Y, Ueda K, Hojo M, Nojiri S, Yao T, Nagahara A.   +17 more
europepmc   +1 more source

Management of uninvestigated dyspepsia: A randomized, double-blind, placebo-controlled trial of proton pump inhibitor therapy

, 2001
Linda Rabeneck, Julianne Souchek, Kimberly Wristers, Terri Menke, Naomi R. Wray, Eunice Ambriz, Iris W. Huang   +6 more
openalex   +1 more source

Development of a consolidated bioprocess for the production of citric acid using Aspergillus niger as biocatalyst

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The industrial production of citric acid, an ingredient in beverages, pharmaceuticals, and cosmetics, is based on microbial fermentation of glucose or sucrose. Given the elevated cost of these sugars, lignocellulosic biomass is emerging as a cost‐effective and environmentally friendly feedstock for sustainable bioprocesses.
Ludovica Varriale, Katrin Kuka, Nils Tippkötter, Lisbeth Olsson, Roland Ulber   +4 more
wiley   +1 more source

Association between preoperative proton pump inhibitor use and postoperative infectious and renal complications following major elective surgery. [PDF]

Can J Surg
Dubois L, McClure JA, Jones PM, Mrkobrada M, Flier S, Welk B, Vogt K.   +6 more
europepmc   +1 more source

Over-the-counter (OTC) H2-receptor antagonists (H2RA) do not compromise the intragastric pH control with proton pump inhibitors (PPI's)

, 2001
Radu Țuțuian, Philip O. Katz, Fawzia Ahmad, Madhu Pamaganamamula, Maria Dipietro, Danald O. Castell   +5 more
openalex   +1 more source

Human vs. artificial intelligence: Physicians outperform ChatGPT in real‐world pharmacotherapy counselling

British Journal of Clinical Pharmacology, EarlyView.
Aims To assess the utility of the artificial intelligence (AI) chatbot ChatGPT (openly available version 3.5) in responding to real‐world pharmacotherapeutic queries from healthcare professionals. Methods Three independent and blinded evaluators with different levels of medical expertise and professional experience (beginner, advanced, and expert ...
Benjamin Krichevsky, Stefan Engeli, Stefanie M. Bode‐Böger, Felix Koop, Martin Schulze Westhoff, Sebastian Schröder, Carsten Schumacher, Thorben Pape, Dirk O. Stichtenoth, Johannes Heck   +9 more
wiley   +1 more source

The Duration of Proton Pump Inhibitor Therapy and the Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Khurmatullina AR, Andreev DN, Kucheryavyy YA, Sokolov FS, Beliy PA, Zaborovskiy AV, Maev IV.   +6 more
europepmc   +1 more source

Understanding the Role of pH Regulation and Neutralizing Agents in Organic Acid Production and Growth of Aspergillus oryzae

Biotechnology and Bioengineering, EarlyView.
We show that pH and neutralization strategy strongly influence the growth, pellet morphology, and organic acid production of Aspergillus oryzae. Acidic and alkaline conditions lead to hairy, dispersed pellets, while near‐neutral environments favour compact pellet formation.
Lukas Hartmann, Mark Christopher Martin, Anke Neumann, Dirk Holtmann, Katrin Ochsenreither   +4 more
wiley   +1 more source

A pH‐responsive charge‐reversal liposome with enhanced biofilm penetration for multimodal synergistic therapy of bacterial infections

BMEMat, EarlyView.
This study develops a pH‐responsive, charge‐reversal liposome for treating bacterial biofilm infections. With enhanced penetration capability, the liposome effectively delivers antibacterial agents into biofilms. By integrating photodynamic and photothermal therapies with antibiotics, it significantly eradicates biofilms and accelerates bacteria ...
Ruyue Li, Bo Liu, Cheng Wang, Zhencheng Sun, Shuyi Lv, Liang Tian, Minghui Xiao, Qinyang Zheng, Linqi Shi, Chunlei Zhu   +9 more
wiley   +1 more source